{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:41:26Z","timestamp":1792172486110,"version":"4.4.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-021-08911-z","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:04:12Z","timestamp":1642464252000},"page":"178-193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis"],"prefix":"10.1007","volume":"63","author":[{"given":"Edward K. L.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"issue":"1","key":"8911_CR1","first-page":"183","volume":"45","author":"AYS Lee","year":"2017","unstructured":"Lee AYS (2017) A review of the role and clinical utility of anti-Ro52\/TRIM21 in systemic autoimmunity. Rheumatol Int 45(1):183\u2013191","journal-title":"Rheumatol Int"},{"issue":"1\u20132","key":"8911_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2012.01.014","volume":"39","author":"V Oke","year":"2012","unstructured":"Oke V, Wahren-Herlenius M (2012) The immunobiology of Ro52 (TRIM21) in autoimmunity: a critical review. J Autoimmun 39(1\u20132):77\u201382","journal-title":"J Autoimmun"},{"issue":"1","key":"8911_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4049\/jimmunol.102.1.117","volume":"102","author":"G Clark","year":"1969","unstructured":"Clark G, Reichlin M, Tomasi TB Jr (1969) Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus. J Immunol 102(1):117\u2013122","journal-title":"J Immunol"},{"issue":"3","key":"8911_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4049\/jimmunol.96.3.464","volume":"96","author":"EM Tan","year":"1966","unstructured":"Tan EM, Kunkel HG (1966) Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol 96(3):464\u2013471","journal-title":"J Immunol"},{"issue":"5","key":"8911_CR5","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1172\/JCI108007","volume":"55","author":"MA Alspaugh","year":"1975","unstructured":"Alspaugh MA, Tan EM (1975) Antibodies to cellular antigens in Sjogren\u2019s syndrome. J Clin Invest 55(5):1067\u20131073","journal-title":"J Clin Invest"},{"issue":"7","key":"8911_CR6","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/art.1780220719","volume":"22","author":"M Alspaugh","year":"1979","unstructured":"Alspaugh M, Maddison P (1979) Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and Sjogren\u2019s syndrome: an interlaboratory collaboration. Arthritis Rheum 22(7):796\u2013798","journal-title":"Arthritis Rheum"},{"issue":"2","key":"8911_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0090-1229(88)90066-9","volume":"47","author":"EM Tan","year":"1988","unstructured":"Tan EM et al (1988) Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 47(2):121\u2013141","journal-title":"Clin Immunol Immunopathol"},{"issue":"12","key":"8911_CR8","first-page":"1138","volume":"1","author":"JP Hendrick","year":"1981","unstructured":"Hendrick JP et al (1981) Ro small cytoplasmic ribonucleoproteins are a subclass of La ribonucleoproteins: further characterization of the Ro and La small ribonucleoproteins from uninfected mammalian cells. Mol Cell Biol 1(12):1138\u20131149","journal-title":"Mol Cell Biol"},{"issue":"7","key":"8911_CR9","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1073\/pnas.81.7.1996","volume":"81","author":"SL Wolin","year":"1984","unstructured":"Wolin SL, Steitz JA (1984) The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAs. Proc Natl Acad Sci U S A 81(7):1996\u20132000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"8911_CR10","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1084\/jem.167.5.1560","volume":"167","author":"E Ben-Chetrit","year":"1988","unstructured":"Ben-Chetrit E et al (1988) A 52-kD protein is a novel component of the SS-A\/Ro antigenic particle. J Exp Med 167(5):1560\u20131571","journal-title":"J Exp Med"},{"key":"8911_CR11","doi-asserted-by":"crossref","unstructured":"Chan EKL, Buyon JP (1994) The SS-A\/Ro antigen. In: Manual of Biological Markers of Disease.\u00a0Springer, Dordrecht, Netherlands, Dordrecht, pp 402\u2013431","DOI":"10.1007\/978-94-011-5444-4_15"},{"issue":"2","key":"8911_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0022-1759(90)90440-7","volume":"129","author":"JP Buyon","year":"1990","unstructured":"Buyon JP et al (1990) Effective separation of the 52 kDa SSA\/Ro polypeptide from the 48 kDa SSB\/La polypeptide by altering conditions of polyacrylamide gel electrophoresis. J Immunol Methods 129(2):207\u2013210","journal-title":"J Immunol Methods"},{"issue":"1","key":"8911_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2249.1991.tb05780.x","volume":"86","author":"RL Slobbe","year":"1991","unstructured":"Slobbe RL et al (1991) Detection and occurrence of the 60- and 52-kD Ro (SS-A) antigens and of autoantibodies against these proteins. Clin Exp Immunol 86(1):99\u2013105","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"8911_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1172\/JCI115003","volume":"87","author":"EKL Chan","year":"1991","unstructured":"Chan EKL et al (1991) Molecular definition and sequence motifs of the 52-kD component of human SS-A\/Ro autoantigen. J Clin Invest 87(1):68\u201376","journal-title":"J Clin Invest"},{"key":"8911_CR15","doi-asserted-by":"crossref","unstructured":"Itoh K, Itoh Y, Frank MB (1991)\u00a0Protein heterogeneity in the human Ro\/SSA ribonucleoproteins. The 52- and 60-kD Ro\/SSA autoantigens are encoded by separate genes. J Clin Invest\u00a087(1):177\u201386","DOI":"10.1172\/JCI114968"},{"issue":"2","key":"8911_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0304-4165(01)00212-4","volume":"1568","author":"D Wang","year":"2001","unstructured":"Wang D et al (2001) Leucine zipper domain of 52 kDa SS-A\/Ro promotes protein dimer formation and inhibits in vitro transcription activity. Biochim Biophys Acta 1568(2):155\u2013161","journal-title":"Biochim Biophys Acta"},{"key":"8911_CR17","doi-asserted-by":"crossref","unstructured":"Buyon JP et al (1989)\u00a0Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA\/Ro-SSB\/La system in neonatal lupus. J Clin Invest\u00a084(2):627\u201334","DOI":"10.1172\/JCI114208"},{"issue":"3","key":"8911_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/art.1780330307","volume":"33","author":"E Ben-Chetrit","year":"1990","unstructured":"Ben-Chetrit E, Fox RI, Tan EM (1990) Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjogren\u2019s syndrome. Arthritis Rheum 33(3):349\u2013355","journal-title":"Arthritis Rheum"},{"issue":"3","key":"8911_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1365-2249.1994.tb07010.x","volume":"95","author":"V Ricchiuti","year":"1994","unstructured":"Ricchiuti V et al (1994) Epitope mapping with synthetic peptides of 52-kD SSA\/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera. Clin Exp Immunol 95(3):397\u2013407","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"8911_CR20","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/jcp.2006.040360","volume":"60","author":"DM Langguth","year":"2007","unstructured":"Langguth DM et al (2007) Specific testing for \u201cisolated\u201d anti-52 kDa SSA\/Ro antibodies during standard anti-extractable nuclear antigen testing is of limited clinical value. J Clin Pathol 60(6):670\u2013673","journal-title":"J Clin Pathol"},{"issue":"5","key":"8911_CR21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.reuma.2015.10.010","volume":"12","author":"R Menor Almagro","year":"2016","unstructured":"Menor Almagro R et al (2016) Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez. Spain Reumatol Clin 12(5):256\u2013262","journal-title":"Spain Reumatol Clin"},{"issue":"5","key":"8911_CR22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1006\/jaut.1995.0052","volume":"8","author":"CL Keech","year":"1995","unstructured":"Keech CL, Gordon TP, McCluskey J (1995) Cytoplasmic accumulation of the 52 kDa Ro\/SS-A nuclear autoantigen in transfected cell lines. J Autoimmun 8(5):699\u2013712","journal-title":"J Autoimmun"},{"issue":"1","key":"8911_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-2249.1997.510-ce1406.x","volume":"110","author":"M Schmitz","year":"1997","unstructured":"Schmitz M et al (1997) Characterization of murine monoclonal antibodies against the Ro52 autoantigen. Clin Exp Immunol 110(1):53\u201362","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"8911_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jaut.2003.11.004","volume":"22","author":"S Salomonsson","year":"2004","unstructured":"Salomonsson S et al (2004) Cloning and characterization of two human Ro52-specific monoclonal autoantibodies directed towards a domain associated with congenital heart block. J Autoimmun 22(2):167\u2013177","journal-title":"J Autoimmun"},{"key":"8911_CR25","doi-asserted-by":"crossref","unstructured":"Itoh Y et al (1992)\u00a0Autoantibodies to the Ro\/SSA autoantigen are conformation dependent. II: antibodies to the denatured form of 52 kD Ro\/SSA are a cross reacting subset of antibodies to the native 60 kD Ro\/SSA molecule. Autoimmunity\u00a014(2):89\u201395","DOI":"10.3109\/08916939209083125"},{"key":"8911_CR26","doi-asserted-by":"crossref","unstructured":"Mahler M et al (2014)\u00a0Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res\u00a02014:315179","DOI":"10.1155\/2014\/315179"},{"issue":"7","key":"8911_CR27","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.4049\/jimmunol.152.7.3675","volume":"152","author":"JP Buyon","year":"1994","unstructured":"Buyon JP et al (1994) Autoantibody responses to the \u201cnative\u201d 52-kDa SS-A\/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjogren\u2019s syndrome. J Immunol 152(7):3675\u20133684","journal-title":"J Immunol"},{"issue":"10","key":"8911_CR28","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1002\/art.21289","volume":"52","author":"RM Clancy","year":"2005","unstructured":"Clancy RM et al (2005) Maternal antibody responses to the 52-kd SSA\/RO p200 peptide and the development of fetal conduction defects. Arthritis Rheum 52(10):3079\u20133086","journal-title":"Arthritis Rheum"},{"issue":"1","key":"8911_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1084\/jem.20041859","volume":"201","author":"S Salomonsson","year":"2005","unstructured":"Salomonsson S et al (2005) Ro\/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 201(1):11\u201317","journal-title":"J Exp Med"},{"key":"8911_CR30","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.3389\/fimmu.2018.02835","volume":"9","author":"A Gkoutzourelas","year":"2018","unstructured":"Gkoutzourelas A et al (2018) Anti-Ro60 seropositivity determines anti-Ro52 epitope mapping in patients with systemic sclerosis. Front Immunol 9:2835","journal-title":"Front Immunol"},{"issue":"10","key":"8911_CR31","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1136\/ard.61.10.929","volume":"61","author":"I Peene","year":"2002","unstructured":"Peene I et al (2002) Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease. Ann Rheum Dis 61(10):929\u2013933","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8911_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1006\/jaut.1997.0171","volume":"11","author":"N Pourmand","year":"1998","unstructured":"Pourmand N, Pettersson I (1998) The Zn2+ binding domain of the human Ro 52 kDa protein is a target for conformation-dependent autoantibodies. J Autoimmun 11(1):11\u201317","journal-title":"J Autoimmun"},{"issue":"2","key":"8911_CR33","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/liv.12658","volume":"35","author":"K Zachou","year":"2015","unstructured":"Zachou K et al (2015) Anti-SLA\/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis. Liver Int 35(2):660\u2013672","journal-title":"Liver Int"},{"issue":"2","key":"8911_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1177\/0961203315624024","volume":"25","author":"P Brito-Zeron","year":"2016","unstructured":"Brito-Zeron P et al (2016) Autoimmune congenital heart block: complex and unusual situations. Lupus 25(2):116\u2013128","journal-title":"Lupus"},{"key":"8911_CR35","doi-asserted-by":"crossref","unstructured":"Rhodes DA, Trowsdale J (2007) TRIM21 is a trimeric protein that binds IgG Fc via the B30.2 domain. Mol Immunol\u00a044(9):2406\u201314","DOI":"10.1016\/j.molimm.2006.10.013"},{"issue":"6","key":"8911_CR36","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1046\/j.1365-3083.1999.00547.x","volume":"49","author":"Y Yang","year":"1999","unstructured":"Yang Y et al (1999) Protein-protein interactions between native Ro52 and immunoglobulin G heavy chain. Scand J Immunol 49(6):620\u2013628","journal-title":"Scand J Immunol"},{"issue":"15","key":"8911_CR37","doi-asserted-by":"publisher","first-page":"6200","DOI":"10.1073\/pnas.0609174104","volume":"104","author":"LC James","year":"2007","unstructured":"James LC et al (2007) Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function. Proc Natl Acad Sci U S A 104(15):6200\u20136205","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"8911_CR38","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1093\/emboj\/20.9.2140","volume":"20","author":"A Reymond","year":"2001","unstructured":"Reymond A et al (2001) The tripartite motif family identifies cell compartments. EMBO J 20(9):2140\u20132151","journal-title":"EMBO J"},{"issue":"10","key":"8911_CR39","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nrmicro1248","volume":"3","author":"S Nisole","year":"2005","unstructured":"Nisole S, Stoye JP, Saib A (2005) TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 3(10):799\u2013808","journal-title":"Nat Rev Microbiol"},{"issue":"10","key":"8911_CR40","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.4049\/jimmunol.176.10.6277","volume":"176","author":"A Espinosa","year":"2006","unstructured":"Espinosa A et al (2006) The Sjogren\u2019s syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death. J Immunol 176(10):6277\u20136285","journal-title":"J Immunol"},{"issue":"1","key":"8911_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bbrc.2005.11.029","volume":"339","author":"K Wada","year":"2006","unstructured":"Wada K, Kamitani T (2006) Autoantigen Ro52 is an E3 ubiquitin ligase. Biochem Biophys Res Commun 339(1):415\u2013421","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"8911_CR42","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1084\/jem.20090585","volume":"206","author":"A Espinosa","year":"2009","unstructured":"Espinosa A et al (2009) Loss of the lupus autoantigen Ro52\/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J Exp Med 206(8):1661\u20131671","journal-title":"J Exp Med"},{"issue":"46","key":"8911_CR43","doi-asserted-by":"publisher","first-page":"19985","DOI":"10.1073\/pnas.1014074107","volume":"107","author":"DL Mallery","year":"2010","unstructured":"Mallery DL et al (2010) Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Natl Acad Sci U S A 107(46):19985\u201319990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8911_CR44","doi-asserted-by":"crossref","unstructured":"Watkinson RE, McEwan WA, James LC (2014)\u00a0Intracellular antibody immunity. J Clin Immunol\u00a034 Suppl 1(9):S30\u20134","DOI":"10.1007\/s10875-014-0017-4"},{"key":"8911_CR45","doi-asserted-by":"crossref","unstructured":"Clift D et al (2017)\u00a0A method for the acute and rapid degradation of endogenous proteins. Cell\u00a0171(7):1692\u20131706 e18","DOI":"10.1016\/j.cell.2017.10.033"},{"issue":"6","key":"8911_CR46","first-page":"1073","volume":"21","author":"DP McCauliffe","year":"1994","unstructured":"McCauliffe DP et al (1994) Autoimmune sera react with multiple epitopes on recombinant 52 and 60 kDa Ro(SSA) proteins. J Rheumatol 21(6):1073\u20131080","journal-title":"J Rheumatol"},{"issue":"7","key":"8911_CR47","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.autrev.2009.02.010","volume":"8","author":"J Schulte-Pelkum","year":"2009","unstructured":"Schulte-Pelkum J, Fritzler M, Mahler M (2009) Latest update on the Ro\/SS-A autoantibody system. Autoimmun Rev 8(7):632\u2013637","journal-title":"Autoimmun Rev"},{"issue":"8","key":"8911_CR48","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/rheumatology\/kep145","volume":"48","author":"B Hervier","year":"2009","unstructured":"Hervier B et al (2009) Clinical significance of anti-Ro\/SSA-52 kDa antibodies: a retrospective monocentric study. Rheumatology (Oxford) 48(8):964\u2013967","journal-title":"Rheumatology (Oxford)"},{"key":"8911_CR49","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.curtheres.2014.06.004","volume":"76","author":"YP Guo","year":"2014","unstructured":"Guo YP et al (2014) The prevalence of antinuclear antibodies in the general population of china: a cross-sectional study. Curr Ther Res Clin Exp 76:116\u2013119","journal-title":"Curr Ther Res Clin Exp"},{"issue":"4","key":"8911_CR50","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/art.1780290401","volume":"29","author":"JA Hardin","year":"1986","unstructured":"Hardin JA (1986) The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 29(4):457\u2013460","journal-title":"Arthritis Rheum"},{"issue":"3","key":"8911_CR51","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1365-2249.1995.tb03728.x","volume":"100","author":"G Boire","year":"1995","unstructured":"Boire G et al (1995) Purification of antigenically intact Ro ribonucleoproteins; biochemical and immunological evidence that the 52-kD protein is not a Ro protein. Clin Exp Immunol 100(3):489\u2013498","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"8911_CR52","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/art.1780400523","volume":"40","author":"CE Tseng","year":"1997","unstructured":"Tseng CE et al (1997) The 52-kd protein as a target of intermolecular spreading of the immune response to components of the SS-A\/Ro-SS-B\/La complex. Arthritis Rheum 40(5):936\u2013944","journal-title":"Arthritis Rheum"},{"issue":"3","key":"8911_CR53","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1073\/pnas.92.3.875","volume":"92","author":"F Topfer","year":"1995","unstructured":"Topfer F, Gordon T, McCluskey J (1995) Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc Natl Acad Sci U S A 92(3):875\u2013879","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"8911_CR54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1191\/096120398678919606","volume":"7","author":"G Kinoshita","year":"1998","unstructured":"Kinoshita G et al (1998) Spreading of the immune response from 52 kDaRo and 60 kDaRo to calreticulin in experimental autoimmunity. Lupus 7(1):7\u201311","journal-title":"Lupus"},{"issue":"8","key":"8911_CR55","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.4049\/jimmunol.157.8.3694","volume":"157","author":"CL Keech","year":"1996","unstructured":"Keech CL, Gordon TP, McCluskey J (1996) The immune response to 52-kDa Ro and 60-kDa Ro is linked in experimental autoimmunity. J Immunol 157(8):3694\u20133699","journal-title":"J Immunol"},{"issue":"4","key":"8911_CR56","doi-asserted-by":"publisher","first-page":"R78","DOI":"10.1186\/ar2276","volume":"9","author":"M Koenig","year":"2007","unstructured":"Koenig M et al (2007) Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther 9(4):R78","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"8911_CR57","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1046\/j.1365-2249.1997.4761369.x","volume":"109","author":"PJ Venables","year":"1997","unstructured":"Venables PJ (1997) Antibodies to Jo-1 and Ro-52: why do they go together? Clin Exp Immunol 109(3):403\u2013405","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"8911_CR58","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/00002281-199609000-00016","volume":"8","author":"JP Buyon","year":"1996","unstructured":"Buyon JP (1996) Neonatal lupus. Curr Opin Rheumatol 8(5):485\u2013490","journal-title":"Curr Opin Rheumatol"},{"key":"8911_CR59","doi-asserted-by":"crossref","unstructured":"Buyon JP et al (1993)\u00a0Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A\/Ro and anti-SS-B\/La antibodies. Arthritis Rheum\u00a036(9):1263\u201373","DOI":"10.1002\/art.1780360911"},{"issue":"11","key":"8911_CR60","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/art.1780371120","volume":"37","author":"M Reichlin","year":"1994","unstructured":"Reichlin M et al (1994) Concentration of autoantibodies to native 60-kd Ro\/SS-A and denatured 52-kd Ro\/SS-A in eluates from the heart of a child who died with congenital complete heart block. Arthritis Rheum 37(11):1698\u20131703","journal-title":"Arthritis Rheum"},{"issue":"9","key":"8911_CR61","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.autrev.2011.03.004","volume":"10","author":"P Ghillani","year":"2011","unstructured":"Ghillani P et al (2011) Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study. Autoimmun Rev 10(9):509\u2013513","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8911_CR62","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/0016-5085(94)90078-7","volume":"107","author":"AJ Czaja","year":"1994","unstructured":"Czaja AJ et al (1994) Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology 107(1):200\u2013207","journal-title":"Gastroenterology"},{"issue":"6","key":"8911_CR63","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1023\/A:1018880429469","volume":"43","author":"S Parveen","year":"1998","unstructured":"Parveen S et al (1998) Antibodies to Ro\/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia: patterns of immunofluorescence, ELISA reactivities, and HLA association. Dig Dis Sci 43(6):1322\u20131331","journal-title":"Dig Dis Sci"},{"key":"8911_CR64","doi-asserted-by":"crossref","unstructured":"Montano-Loza AJ et al (2011)\u00a0Prognostic implications of antibodies to Ro\/SSA and soluble liver antigen in type 1 autoimmune hepatitis. Liver Int","DOI":"10.1111\/j.1478-3231.2011.02502.x"},{"issue":"6","key":"8911_CR65","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1478-3231.2009.01986.x","volume":"29","author":"V Eyraud","year":"2009","unstructured":"Eyraud V et al (2009) Significance of antibodies to soluble liver antigen\/liver pancreas: a large French study. Liver Int 29(6):857\u2013864","journal-title":"Liver Int"},{"issue":"6","key":"8911_CR66","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1365-2036.2007.03433.x","volume":"26","author":"A Granito","year":"2007","unstructured":"Granito A et al (2007) Antibodies to SS-A\/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. Aliment Pharmacol Ther 26(6):831\u2013838","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"8911_CR67","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0889-857X(21)00737-7","volume":"18","author":"IN Targoff","year":"1992","unstructured":"Targoff IN (1992) Autoantibodies in polymyositis. Rheum Dis Clin North Am 18(2):455\u2013482","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"8911_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","volume":"52","author":"M Satoh","year":"2017","unstructured":"Satoh M et al (2017) A Comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol 52(1):1\u201319","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4\u20135","key":"8911_CR69","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.autrev.2014.01.022","volume":"13","author":"M Mahler","year":"2014","unstructured":"Mahler M, Miller FW, Fritzler MJ (2014) Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Autoimmun Rev 13(4\u20135):367\u2013371","journal-title":"Autoimmun Rev"},{"issue":"1","key":"8911_CR70","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1046\/j.1365-2249.1997.4081308.x","volume":"109","author":"SA Rutjes","year":"1997","unstructured":"Rutjes SA et al (1997) Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol 109(1):32\u201340","journal-title":"Clin Exp Immunol"},{"issue":"1012","key":"8911_CR71","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/pgmj.2009.089656","volume":"86","author":"M Dugar","year":"2010","unstructured":"Dugar M et al (2010) Diagnostic utility of anti-Ro52 detection in systemic autoimmunity. Postgrad Med J 86(1012):79\u201382","journal-title":"Postgrad Med J"},{"issue":"2","key":"8911_CR72","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1006\/jaut.1998.0265","volume":"12","author":"MB Frank","year":"1999","unstructured":"Frank MB et al (1999) The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies. J Autoimmun 12(2):137\u2013142","journal-title":"J Autoimmun"},{"issue":"2","key":"8911_CR73","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/ard.60.2.116","volume":"60","author":"R Brouwer","year":"2001","unstructured":"Brouwer R et al (2001) Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 60(2):116\u2013123","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"8911_CR74","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1136\/annrheumdis-2018-215004","volume":"78","author":"S Sabbagh","year":"2019","unstructured":"Sabbagh S et al (2019) Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis. Ann Rheum Dis 78(7):988\u2013995","journal-title":"Ann Rheum Dis"},{"key":"8911_CR75","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.rmed.2019.07.020","volume":"155","author":"F Chen","year":"2019","unstructured":"Chen F et al (2019) Clinical characteristics of dermatomyositis patients with isolated anti-Ro-52 antibody associated rapid progressive interstitial lung disease: data from the largest single Chinese center. Respir Med 155:127\u2013132","journal-title":"Respir Med"},{"key":"8911_CR76","doi-asserted-by":"crossref","unstructured":"Xing X, Li A, Li C (2020) Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis. Respir Med\u00a0172:106134","DOI":"10.1016\/j.rmed.2020.106134"},{"key":"8911_CR77","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fimmu.2019.00444","volume":"10","author":"A Robbins","year":"2019","unstructured":"Robbins A et al (2019) Diagnostic utility of separate anti-Ro60 and anti-Ro52\/TRIM21 Antibody detection in autoimmune diseases. Front Immunol 10:444","journal-title":"Front Immunol"},{"issue":"11","key":"8911_CR78","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/ard.56.11.667","volume":"56","author":"M Fujimoto","year":"1997","unstructured":"Fujimoto M et al (1997) Prevalence and clinical relevance of 52-kDa and 60-kDa Ro\/SS-A autoantibodies in Japanese patients with systemic sclerosis. Ann Rheum Dis 56(11):667\u2013670","journal-title":"Ann Rheum Dis"},{"key":"8911_CR79","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1740-2557-6-2","volume":"6","author":"JC Parker","year":"2009","unstructured":"Parker JC, Burlingame RW, Bunn CC (2009) Prevalence of antibodies to Ro-52 in a serologically defined population of patients with systemic sclerosis. J Autoimmune Dis 6:2","journal-title":"J Autoimmune Dis"},{"issue":"5","key":"8911_CR80","doi-asserted-by":"publisher","first-page":"R172","DOI":"10.1186\/ar3495","volume":"13","author":"R Mierau","year":"2011","unstructured":"Mierau R et al (2011) Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features. Arthritis Res Ther 13(5):R172","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"8911_CR81","doi-asserted-by":"publisher","first-page":"R50","DOI":"10.1186\/ar3763","volume":"14","author":"M Hudson","year":"2012","unstructured":"Hudson M et al (2012) Clinical significance of antibodies to Ro52\/TRIM21 in systemic sclerosis. Arthritis Res Ther 14(2):R50","journal-title":"Arthritis Res Ther"},{"issue":"4 Suppl 91","key":"8911_CR82","first-page":"S131","volume":"33","author":"M Wodkowski","year":"2015","unstructured":"Wodkowski M et al (2015) Monospecific anti-Ro52\/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival. Clin Exp Rheumatol 33(4 Suppl 91):S131\u2013S135","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"8911_CR83","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","volume":"177","author":"NS Goh","year":"2008","unstructured":"Goh NS et al (2008) Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 177(11):1248\u20131254","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"8911_CR84","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00408-016-9896-x","volume":"194","author":"C Johnson","year":"2016","unstructured":"Johnson C et al (2016) Assessment of mortality in autoimmune myositis with and without associated interstitial lung disease. Lung 194(5):733\u2013737","journal-title":"Lung"},{"issue":"3","key":"8911_CR85","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/08916930600623791","volume":"39","author":"R La Corte","year":"2006","unstructured":"La Corte R et al (2006) In patients with antisynthetase syndrome the occurrence of anti-Ro\/SSA antibodies causes a more severe interstitial lung disease. Autoimmunity 39(3):249\u2013253","journal-title":"Autoimmunity"},{"issue":"9","key":"8911_CR86","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00296-009-0884-9","volume":"29","author":"A Vancsa","year":"2009","unstructured":"Vancsa A et al (2009) Characteristics of interstitial lung disease in SS-A positive\/Jo-1 positive inflammatory myopathy patients. Rheumatol Int 29(9):989\u2013994","journal-title":"Rheumatol Int"},{"key":"8911_CR87","doi-asserted-by":"crossref","unstructured":"Ferreira JP et al (2012)\u00a0Anti-Ro52 antibodies and interstitial lung disease in connective tissue diseases excluding scleroderma. ISRN Rheumatol\u00a02012:415272","DOI":"10.5402\/2012\/415272"},{"issue":"6","key":"8911_CR88","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.semarthrit.2011.09.008","volume":"41","author":"I Marie","year":"2012","unstructured":"Marie I et al (2012) Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody. Semin Arthritis Rheum 41(6):890\u2013899","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"8911_CR89","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/rheumatology\/kev300","volume":"55","author":"R Gunnarsson","year":"2016","unstructured":"Gunnarsson R et al (2016) Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease. Rheumatology (Oxford) 55(1):103\u2013108","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"8911_CR90","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/rheumatology\/kex077","volume":"57","author":"S Reiseter","year":"2018","unstructured":"Reiseter S et al (2018) Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study. Rheumatology (Oxford) 57(2):255\u2013262","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"8911_CR91","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3899\/jrheum.150844","volume":"43","author":"J Bauhammer","year":"2016","unstructured":"Bauhammer J et al (2016) Rituximab in the treatment of Jo1 antibody-associated antisynthetase syndrome: anti-Ro52 positivity as a marker for severity and treatment response. J Rheumatol 43(8):1566\u20131574","journal-title":"J Rheumatol"},{"issue":"7","key":"8911_CR92","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3899\/jrheum.161480","volume":"44","author":"J Shi","year":"2017","unstructured":"Shi J et al (2017) Clinical profiles and prognosis of patients with distinct antisynthetase autoantibodies. J Rheumatol 44(7):1051\u20131057","journal-title":"J Rheumatol"},{"issue":"1","key":"8911_CR93","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12931-019-1231-7","volume":"20","author":"A Sclafani","year":"2019","unstructured":"Sclafani A et al (2019) Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody. Respir Res 20(1):256","journal-title":"Respir Res"},{"key":"8911_CR94","doi-asserted-by":"crossref","unstructured":"Lee A et al (2021)\u00a0Anti-Ro52\/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients. Scand J Rheumatol 1\u20136","DOI":"10.1080\/03009742.2021.1887927"},{"issue":"5","key":"8911_CR95","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1349-7006.2006.00192.x","volume":"97","author":"M Kuboshima","year":"2006","unstructured":"Kuboshima M et al (2006) Presence of serum tripartite motif-containing 21 antibodies in patients with esophageal squamous cell carcinoma. Cancer Sci 97(5):380\u2013386","journal-title":"Cancer Sci"},{"issue":"3","key":"8911_CR96","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/rheumatology\/39.3.253","volume":"39","author":"W Lawley","year":"2000","unstructured":"Lawley W et al (2000) Rapid lupus autoantigen relocalization and reactive oxygen species accumulation following ultraviolet irradiation of human keratinocytes. Rheumatology 39(3):253\u2013261","journal-title":"Rheumatology"},{"issue":"5","key":"8911_CR97","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1046\/j.1365-3083.2002.01072_79.x","volume":"56","author":"M Ohlsson","year":"2002","unstructured":"Ohlsson M, Jonsson R, Brokstad KA (2002) Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjogren\u2019s syndrome. Scand J Immunol 56(5):456\u2013469","journal-title":"Scand J Immunol"},{"issue":"9","key":"8911_CR98","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1158\/1055-9965.EPI-15-0047","volume":"24","author":"J Wang","year":"2015","unstructured":"Wang J et al (2015) Plasma autoantibodies associated with basal-like breast cancers. Cancer Epidemiol Biomarkers Prev 24(9):1332\u20131340","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"8911_CR99","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3233\/CBM-170652","volume":"20","author":"M Chatterjee","year":"2017","unstructured":"Chatterjee M et al (2017) Utility of paraneoplastic antigens as biomarkers for surveillance and prediction of recurrence in ovarian cancer. Cancer Biomark 20(4):369\u2013387","journal-title":"Cancer Biomark"},{"issue":"3","key":"8911_CR100","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3233\/CBM-190988","volume":"27","author":"LC Hurley","year":"2020","unstructured":"Hurley LC et al (2020) Evaluation of paraneoplastic antigens reveals TRIM21 autoantibodies as biomarker for early detection of ovarian cancer in combination with autoantibodies to NY-ESO-1 and TP53. Cancer Biomark 27(3):407\u2013421","journal-title":"Cancer Biomark"},{"key":"8911_CR101","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cca.2021.07.006","volume":"521","author":"DP Bogdanos","year":"2021","unstructured":"Bogdanos DP et al (2021) Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer. Clin Chim Acta 521:199\u2013205","journal-title":"Clin Chim Acta"},{"issue":"10","key":"8911_CR102","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1002\/1521-4141(200010)30:10<2782::AID-IMMU2782>3.0.CO;2-9","volume":"30","author":"P Eftekhari","year":"2000","unstructured":"Eftekhari P et al (2000) Anti-SSA\/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block. Eur J Immunol 30(10):2782\u20132790","journal-title":"Eur J Immunol"},{"issue":"3","key":"8911_CR103","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/01.RES.80.3.354","volume":"80","author":"M Boutjdir","year":"1997","unstructured":"Boutjdir M et al (1997) Arrhythmogenicity of IgG and anti-52-kD SSA\/Ro affinity-purified antibodies from mothers of children with congenital heart block. Circ Res 80(3):354\u2013362","journal-title":"Circ Res"},{"issue":"4","key":"8911_CR104","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/art.20130","volume":"50","author":"PE Lazzerini","year":"2004","unstructured":"Lazzerini PE et al (2004) Prolongation of the corrected QT interval in adult patients with anti-Ro\/SSA-positive connective tissue diseases. Arthritis Rheum 50(4):1248\u20131252","journal-title":"Arthritis Rheum"},{"issue":"4","key":"8911_CR105","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/CIRCULATIONAHA.115.009800","volume":"132","author":"Y Yue","year":"2015","unstructured":"Yue Y et al (2015) Pathogenesis of the Novel Autoimmune-Associated Long-QT Syndrome. Circulation 132(4):230\u2013240","journal-title":"Circulation"},{"key":"8911_CR106","doi-asserted-by":"crossref","unstructured":"Lazzerini PE et al (2021)\u00a0Risk of QTc interval prolongation associated with circulating anti-Ro\/SSA antibodies among US veterans: an observational cohort study. J Am Heart Assoc\u00a010(4):e018735","DOI":"10.1161\/JAHA.120.018735"},{"issue":"3","key":"8911_CR107","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1136\/annrheumdis-2014-206297","volume":"75","author":"BM Szczerba","year":"2016","unstructured":"Szczerba BM et al (2016) Interaction between innate immunity and Ro52-induced antibody causes Sjogren\u2019s syndrome-like disorder in mice. Ann Rheum Dis 75(3):617\u2013622","journal-title":"Ann Rheum Dis"},{"key":"8911_CR108","doi-asserted-by":"crossref","unstructured":"Julkunen H et al (1993)\u00a0Isolated congenital heart block. Long-term outcome of mothers and characterization of the immune response to SS-A\/Ro and to SS-B\/La. Arthritis Rheum\u00a036(11):1588\u201398","DOI":"10.1002\/art.1780361114"},{"issue":"5","key":"8911_CR109","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/art.10232","volume":"46","author":"S Salomonsson","year":"2002","unstructured":"Salomonsson S et al (2002) A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 46(5):1233\u20131241","journal-title":"Arthritis Rheum"},{"issue":"12","key":"8911_CR110","first-page":"2480","volume":"31","author":"P Gordon","year":"2004","unstructured":"Gordon P et al (2004) Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus. J Rheumatol 31(12):2480\u20132487","journal-title":"J Rheumatol"},{"issue":"2","key":"8911_CR111","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.autrev.2012.07.005","volume":"12","author":"D Villalta","year":"2012","unstructured":"Villalta D et al (2012) Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis. Autoimmun Rev 12(2):114\u2013120","journal-title":"Autoimmun Rev"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08911-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-021-08911-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08911-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T13:24:45Z","timestamp":1673529885000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-021-08911-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":111,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["8911"],"URL":"https:\/\/doi.org\/10.1007\/s12016-021-08911-z","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,18]]},"assertion":[{"value":"29 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The author declares no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest\/Competing Interests"}}]}}